Dapagliflozin Reduces Risk of Kidney Failure
Recently was confirmed, that treatment with dapagliflozin (Farxiga; AstraZeneca) reduced the risk of kidney failure and cardiovascular (CV) or renal death in patients with chronic…
Recently was confirmed, that treatment with dapagliflozin (Farxiga; AstraZeneca) reduced the risk of kidney failure and cardiovascular (CV) or renal death in patients with chronic…
According to the information from the European Society of Cardiology’s (ESC) virtual annual meeting, which was at August 29 Vascepa cut patients’ coronary plaque by…
At August 26 Abbott Park announced that FDA authorized their BinaxNOW COVID-19 Ag Card rapid test. The Emergency Use Authorization (EUA) were given through the…
The FDA Okayed first in The US oral solid solutions from Mylan for MS treatment.MS (Multiple Sclerosis) is The disease mainly occurs at a young…
17 August media got the information about the FDA approvement for Enspryng (Genentech) Satralizumab-mwge for the treatment of neuromyelitis optica spectrum disorder (MNOSD) in adults…
A few days ago AstraZeneca stated their first intranasal influenza vaccine live (FluMist Quadrivalent) doses shipping in the USA, to prepare for the flu season…
A few days ago FDA officially okayed risdiplam (Evrysdi; Genentech) for the treatment of spinal muscular atrophy (SMA) for adults and children not younger than…
Esketamine (Spravato; Janssen) CIII nasal spray is the first FDA-approved antidepressant medication that improves depressive symptoms with the first dose in adults with major depressive…
On July 31, The Food and Drug Administration (FDA) has approved seizures treatment containing cannabidiol (CBD) (Epidiolex, Greenwich Biosciences Inc). This is an oral solution…
The U.S. Food and Drug Administration (FDA) has approved Uplizna injection for intravenous use for the therapy of neuromyelitis optica spectrum disorder (NMOSD) that affects…